ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CD BioSciences Announces Standardized Biofilm Quantification Services with Cutting-Edge Technologies

By: Get News
CD BioSciences announced its standardized biofilm quantitative characterization services, aiming to deliver precise, reproducible, and scalable solutions for biofilm analysis.

New York, USA - May 28, 2025 - CD BioSciences releases standardized biofilm quantification services that use advanced technologies to provide accurate, repeatable, and future-proof solutions for biofilm testing. This complete package delivers powerful toolkit to study the structure, composition and dynamics of biofilm in high fidelity.

Biofilms, complex microbial communities embedded in extracellular polymeric substances (EPS), play critical roles in medical, environmental, and industrial applications. Traditional quantification methods often lack standardization, leading to inconsistent results. Understanding their properties is essential for combating antibiotic resistance, improving bioremediation, and optimizing industrial processes. CD BioSciences now enables scientists to obtain detailed, quantitative biofilm data through a suite of advanced technologies and equipment, including:

Confocal Laser Scanning Microscopy (CLSM) - High-resolution 3D imaging of biofilm architecture.

Scanning Electron Microscopy (SEM) - Ultra-detailed surface morphology analysis.

Microfluidic Flow Systems - Real-time monitoring of biofilm development under dynamic conditions.

Raman Spectroscopy & FTIR - Chemical composition mapping of EPS and microbial cells.

qPCR & Next-Generation Sequencing (NGS) - Molecular-level insights into biofilm microbial diversity.

"Accurate biofilm quantification is crucial for both fundamental research and industrial applications," said a senior scientist at CD BioSciences. "Our integrated services eliminate technical barriers, allowing clients to focus on their scientific goals while we deliver reproducible, high-quality data tailored to their needs."

Why Choose CD BioSciences?

Multi-Technology Approach - CD BioSciences provides direct and indirect quantitative methods. Direct counting methods allow counting of culturable cells, including plate counting, microscopic cell counting, Coulter cell counting, flow cytometry, and fluorescence microscopy. Indirect measurement methods include determination of dry weight, total organic carbon, microtiter plate assay, ATP bioluminescence, total protein, and quartz crystal microbalances. Clients can select the most suitable methods for their specific research questions.

Customizable Protocols - Services are adaptable for biofilms in pharmaceutical, environmental, or industrial settings. From sample preparation to data interpretation, CD BioSciences can provide custom biofilm analysis solutions.

Fast Turnaround & Competitive Pricing - Streamlined workflows ensure efficient project completion.

CD BioSciences' biofilm characterization services are now available to academic institutions, pharmaceutical companies, and biotechnology firms worldwide. For more information or to request a quote, visit www.biofilma.com.

About CD BioSciences

CD BioSciences is a global leader in life sciences research support, offering specialized services in microbiology, molecular biology, and bioimaging. With a commitment to innovation and precision, the company empowers scientists to accelerate discoveries across multiple disciplines.

Follow Us on: Facebook | Twitter | LinkedIn

Media Contact
Company Name: CD BioSciences
Contact Person: Kikiwi Davis
Email: Send Email
Phone: 1-315-636-4280
Country: United States
Website: https://www.biofilma.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.65
+5.59 (2.40%)
AAPL  262.74
-4.52 (-1.69%)
AMD  213.81
-7.27 (-3.29%)
BAC  57.14
+0.25 (0.44%)
GOOG  312.75
-4.57 (-1.44%)
META  655.30
-3.49 (-0.53%)
MSFT  472.34
-0.51 (-0.11%)
NVDA  188.79
+0.67 (0.36%)
ORCL  193.67
+1.08 (0.56%)
TSLA  432.79
-18.88 (-4.18%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.